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Aims: This study was planned to assess the development of cardiovascular disease (CVD)
events over an 11-year period and to identify the associated risk factors that could predict
the onset of CVD among subjects with type 2 diabetes.
Methods: Retrospective data of 249 patients (M:F 149:100) with type 2 diabetes, from a cohort
of 7800 patients, attending a tertiary care center for diabetes from January 2000 to
December 2011 were retrieved and analyzed for this study. Sociodemographic and habitual
risk factors, baseline diabetes duration, HbA1c and time of onset of CVD and its risk factors
were collected from case records. Person-years method was used to calculate incident rate
of CVD. Binary logistic regression analyses were done to identify predictors associated with
CVD and its risk factors.
Results: Incidence of CVD among subjects with diabetes was 5.6 cases/1000 person-years.
Nearly 60% developed hypertension and dyslipidemia or both during the 11-year period.
The most common complication was neuropathy (14.4%). Smoking [OR (95%CI)] [9.26 (1.6
e54.9)] (p ¼ 0.014) and heavy alcohol consumption [8.7 (1.1e69.8)] (p ¼ 0.04) were signifi-
cantly associated with CVD. Higher BMI was significantly associated with hypertension and
dyslipidemia [2.4 (1.3e4.3)] (p ¼ 0.003).
Conclusions: Smoking and heavy alcohol consumption were significantly associated with
CVD, and increased BMI was significantly associated with hypertension and dyslipidemia
among subjects with type 2 diabetes in this study population. These findings emphasize
the need for early identification and modification of risk factors associated with CVD
events in patients with diabetes.
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The global burden of diabetes is enormous, with an estimated
366 million people living with diabetes worldwide in 2011.1
India accounted for nearly one-sixth of global diabetes
burden in 2011 with about 62 million people affected by dia-
betes.2 Regarding the mortality associated with diabetes,
globally there were 4.6 million deaths due to diabetes ac-
counting for 8.2% from all causes of mortality. About 48% of
the deaths attributed to diabetes had occurred in the people
aged below 60 years. In India, 983,000 deaths were attributed
to diabetes in 2011.1 Cardiovascular disease (CVD) is themajor
cause of death in diabetes and accounts for one-half of all the
deaths due to diabetes.3 Developing countries like India would
bear the greater impact of mortality and morbidity associated
with diabetes and CVD, as 70e80% of these deaths are ex-
pected to occur in such countries.4
A caseecontrol study conducted between subjects with
diabetes and thosewithout diabetes in urban South India with
a median follow-up period of 6 years compared the mortality
rate between the two groups and showed a significant two-
fold increase in deaths among subjects with diabetes. The
study also reported that mortality rate due to CVD in subjects
with diabeteswas 52.9%,while it was only 24.2% in the normal
counterparts.5 A retrospective study on the causes of mor-
tality due to diabetes in a tertiary care center from India re-
ported vascular diseases as the foremost cause of death in two
age groups i.e. more than and less than 56 years among the
hospitalized inpatients.6 This higher rate of premature deaths
in diabetes due to CVD can be attributed to the constellation of
recognized risk factors such as elevated blood pressure,
increased adiposity and hyperglycemic state.7
Numerous studies had reported that the basic changes
occurring at the vascular level are mediated through insulin
resistance in subjects with diabetes as well as prediabetes.8 In
addition, the role of advanced glycation end products in
causing premature atherosclerosis and thereby leading to
death has also been reported among Finnish women with
diabetes.9 Insulin resistance has been associated with
increased serum levels of inflammatory markers such as C-
reactive protein (CRP), interleukin-6 and tumor necrosis fac-
tor-a, which also play a major role in the vascular endothelial
changes in patients with diabetes. Soinio et al10 reported that
patients with type 2 diabetes with high levels of hs-CRP
(3 mg/l) were more likely to have deaths due to coronary
heart disease. Several studies had reported the interlinked
pathophysiology behind the increased risk of CVD among
patients with type 2 diabetes with inconclusive evidences.
Eddy et al11 had simulated a study based on Archimedes
model and reported that 42% of myocardial infarction can be
prevented by controlling insulin resistance among young
adults.
The above-mentioned studies confirm the strong associa-
tion of various risk factors, including physiological and in-
flammatorycomponents,with thedevelopmentofCVDamong
patients with diabetes. However, there is a paucity of data on
the incidence of non fatal CVD events in subjects with type 2
diabetes in India. Hence, the current studywas plannedwith a
primary objective to determine the incidence of non fatal CVDevents in patientswith type 2 diabetes attending a tertiary care
center over a period of 11 years and also to identify its associ-
ated risk factors.Thesecondaryobjectivewas toassess therate
of development of CVD risk factors such as hypertension and
dyslipidemia and its associated factors among the same co-
horts using a retrospective cohort study design.2. Patients and methods
A retrospective cohort study design was followed to address
the research question. There were 7800 patients with type 2
diabetes who visited the outpatient department of a tertiary
care center in Chennai, Tamil Nadu, from January to
December 2000. Out of the 7800 patients, only 350 patients
who had 11 years follow-up details, i.e. till December 2011,
were selected for this analysis. Out of 350 patients, 90 subjects
who had complications and comorbid conditions associated
with diabetes at the baseline and 11 subjects with incomplete
data at the baseline were excluded from the analysis. Data of
the remaining 249 patients with diabetes, but without any
complications and other CVD risk factors (hypertension,
dyslipidemia) at baseline and who had undergone annual
screening for the presence of complications of diabetes for a
period of 11 years were included in this analysis. The details
were retrieved from the case records maintained in the
medical records department. A schematic representation of
the recruitment of subjects is illustrated in Fig. 1. Data from
subjects both previously diagnosed with diabetes, and diag-
nosed in the year of 2000 were included in the study.
Socio-demographic details viz., age, gender, habitual risk
factors such as smoking and alcohol consumption, baseline
HbA1c, BMI, duration of diabetes and family history of diabetes
were collected from their case records. The development of
CVD risk factors such as hypertension and dyslipidemia during
the 11 years, if any, was noted and their time of onset from the
baselinewas also recorded. JNCVI andVII criteriawas followed
for the diagnosis of hypertension and similarly, successive
NCEP ATP guidelines were used in diagnosing dyslipidae-
mia.12,13 The occurrence of disorders pertaining to CVD such as
angina, coronary heart disease, peripheral arterial disease and
stroke in the subsequent years from 2000 to 2011 was recorded
from their case records with a confirmative diagnosis made by
the physicians. The tertiary care center followsADA criteria for
the diagnosis of diabetes and its complications.14
The study subjects were categorized into current smokers,
ex-smokersandnon-smokersbasedontheirdetails in their case
records. Non-smokers were those who have never smoked in
their lifetime. Ex-smokers were those who had smoked previ-
ously and stopped smoking at least 6 months prior to the base-
line. Current smokerwas defined as a personwhohad the habit
of smoking regularly. Similarly, alcohol consumers were also
grouped into 3 categories viz., abstainers group (never
consumed alcohol), consumed alcohol occasionally (taking
alcohol in moderate level and the frequency of consumption is
also less than once aweek), andheavydrinkers (who consumed
alcohol for almost all the days in a week and the quantity of
consumption exceeds 50 ml in male and 30 ml in female per
drink).
January - December 
           Excluded 
Presence of complications  
Excluded 
Missing data in the Baseline
N = 7800 Year 2000 
N = 7450 
Excluded (not completed 12 years) 
N = 350 
N = 90 
N= 260 
N = 11 
N = 249 
Fig. 1 e Schematic representation of selection of study subjects.
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Mean and standard deviation were reported for continuous
variables, and frequencies and proportion were reported for
categorical variables. The incident rate of CVD among the
study cohort was calculated using person-years method. Bi-
nary logistic regression analysis was done with the develop-
ment of CVD events vs. non development of CVD events as
dependent variable and the independent variables were age
(continuous variable), gender (Male vs. female), baseline BMI
(<25 vs. 25 kg/m2), HbA1c [<7.5% (<58 mmol/mol) as refer-
ence group vs. 7.5e9% (58e75 mmol/mol) vs. 9%
(75 mmol/mol)], duration of diabetes (<5 years as reference
group vs. 5e10 and 10 years), positive family history of dia-
betes, smoking habit and alcohol consumption. Another bi-
nary logistic regression was done with the above-mentioned
independent variables and presence of CVD risk factors (hy-
pertension and dyslipidemia) vs. absence of CVD risk factors
as dependent variable to identify the associated factors. Sta-
tistical software SPSS version 16.0 was used for all the statis-
tical analyses. A p value of <0.05 was considered to be
statistically significant.3. Results
Data of 249 subjects (149 males and 100 females) with type 2
diabetes fromthecohortof 7800patientsduring theentireperiod
of11yearswereanalyzedinthisstudy.Themeanageof thestudy
subjectsatbaselinewas55.6 9.7yearsand themedianduration
of diabetes at baseline was 2 years, ranging from 0 to 19 years.
About 64.7% had a positive family history of diabetes. Regarding
the habitual risk factors, 82.3% were non-smokers, 11.2% were
current smokers and another 6.4%were ex-smokers. Nearly 90%
of the study subjects never consumed alcohol, 7.6% consumed
alcohol occasionally and 3.2% were heavy drinkers. At baseline,
63.4%wereonOHA, 0.4%on insulin and36.2%wereonbothOHA
and insulin. The average HbA1c of the study subjects at baseline
was 9.5 2.4% (80  26.2 mmol/mol) (Table 1).3.1. Incidence of CVD among subjects with type 2
diabetes
The incident rate of CVD among the study subjects was 5.6
cases/1000 person-years (95% CI; 3.14e9.26). Among the
Fig. 2 e Gender wise details on proportion of subjects who
developed diabetes related complications.
Table 3 e Result of Binomial logistic regression analysis.
Dependent variable: (CVD events vs. non-CVD).
Table 1 e Baseline characteristics of the study subjects.
Characteristics Values
N (M:F ratio) 249 (149:100)
Values are mean ± SD
Age (yrs) 55.6  9.7
HbA1c [% (mmol/mol)] 9.48  2.44 (80  26.7)
Duration of DM (yrs)a 2 (0e19)
Values are n (%)
Positive family history of DM 161 (64.7)
Smoking
Non smoker 205 (82.3)
Ex-Smoker 16 (6.4)
Regular 28 (11.2)
Alcohol
Never 222 (89.2)
Occasional 19 (7.6)
Regular 8 (3.2)
Body mass index (BMI) kg/m2
Mean BMI 26.8  4
25 kg/m2 164 (65.9%)
Type of medication
OHA 158 (63.4)
Insulin 1 (0.4)
Both 90 (36.2)
a Median (range).
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CVD events during the 11-year period, of which 12 (80%) were
males and 3 (20%) were females. The median period of
development of CVD events was 6 years with a range from 2 to
11 years. The most common reported CVD was peripheral
arterial disease (4%), followed by angina (1.6%) and congestive
cardiac failure (0.4%). All those who had developed angina
were males and only one female had developed congestive
cardiac failure. There was no significant gender difference in
the CVD events (p ¼ 0.08).
Microvascular complications including retinopathy, neu-
ropathy and nephropathywere observed in 52 (20.9%) subjects
as shown in Table 2. Among all the complications, the most
commonly occurring complication was neuropathy in the
study cohort. There was no significant gender difference in
the onset of these complications as observed in the case of
development of CVD. The proportion of male and female pa-
tients with complications is shown in Fig. 2. Although there
was no significant association between gender and develop-
ment of neuropathy, there was a higher rate of development
of neuropathy and PVD in males compared to females.
Irrespective of the presence of other complications, 59.4%
of the study cohort had developed hypertension and/or dys-
lipidemiawithin the time period of 11 years. The proportion ofTable 2 e Development of CVD events and other
complications over the 11-year period among the study
subjects.
Presence of complications and
comorbid conditions
% [95% CI]
CVD events 6 [3.1e9]
Other microvascular complications 20.9 [15.9e26]
Hypertension and/or dyslipidemia 59.4 [53.3e65.5]male subjects (60.1%) that developed hypertension and/or
dyslipidemia was higher than that of the females (39.9%), but
it was not statistically significant. There was no significant
correlation between age and the development of hypertension
and dyslipidemia (p ¼ 0.91). There were 52 (20.8%) of the study
subjects who did not develop any complication or comorbid
condition related to diabetes.
Binomial regression analysis showed that smoking habit
and alcohol consumption were significantly associated with
development of CVD events as given in Table 3. Current
smokers had recorded a higher odds ratio (OR) of 9.3 compared
to subjects without smoking habit (p ¼ 0.014). Similarly, those
who were consuming alcohol heavily had an OR of 8.7 for the
development of CVD events compared to those who never
consumed alcohol (p ¼ 0.04).
The regression analysis also revealed those with BMI
25 kg/m2 at baseline were almost 2.5 times at higher risk of
developing hypertension and dyslipidemia in comparison
with those who had BMI<25 kg/m2 (p ¼ 0.003). All the other
independent variables such as age, sex, positive family history
of diabetes, duration of diabetes, HbA1c categories, smoking
and alcohol consumption did not show any statistically sig-
nificant association with the development of hypertension
and dyslipidemia (Table 4).4. Discussion
This retrospective cohort study on patients with type 2 dia-
betes for a period of 11 years revealed that there is a greaterSignificant variables b S.E Odds ratio
(95% CI)
p value
Non-smokers (reference group)
Ex-smokers 1.39 1.3 0.25 (0.02e3.1) 0.280
Current smokers 2.23 0.9 9.26 (1.6e54.9) 0.014
Abstinence from Alcohol (reference group)
Occasional consumers 19.2 1.34 0.01 (0.001e0.1) 0.9
Heavy drinkers 2.16 1.06 8.7 (1.1e69.8) 0.04
Non-significant variables: age, sex, family history of diabetes,
duration of diabetes, HbA1c, and BMI.
Table 4 e Result of binomial logistic regression analysis.
Dependent variable: presence of CVD risk factors
(hypertension and dyslipidemia) vs. absence of CVD risk
factors.
Significant
variables
b SE b Odds ratio
(95%confidence
interval)
p value
BMI (<25 kg/m2)
reference
group 25 kg/m2
0.882 0.29 2.4 (1.3e4.3) 0.003
Non-significant variables: age, sex, family history of diabetes,
duration of diabetes,, HbA1c, smoking habit and alcohol
consumption.
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disease. Another important highlight of the study was that
about 60% of the patients had developed either hypertension
or dyslipidemia or both during this period.
About 6% of the subjects had developed non fatal CVD over
a period of 11 years. Although there was no significant dif-
ference betweenmale and female in the development of CVD,
the pattern of incidence of certain CVDs such as angina was
predominantly found in males except for only one female
patient who had developed congestive cardiac failure.
Current smokers were 9 times at higher risk of developing
CVD than non-smokers and the association between CVD and
ex-smokers was not significantly associated with CVD among
the study subjects. Such an observation showing the high risk
of developing macrovascular complications among smokers
with diabetes has been previously reported.15
Similarly, patients with heavy consumption of alcohol also
had an eight-fold higher risk of developing CVD than those
who never consumed alcohol. A recent study also showed a
similar result that the risk of developing CVD, particularly
stroke, was significantly high among hypertensive individuals
with a habit of heavy alcohol consumption.16
In the current study, duration of diabetes was not found to
be associated with CVD events. Even the UKPDS had reported
a weaker association between duration of diabetes and inci-
dence of CVD in subjects with diabetes.17 In the present study,
at baseline, nearly 70% of the study subjects had duration of
diabetes less than 5 years, 17.35% of subjects had duration
between 5 and 10 years and 12.8% of subjects had duration of
diabetes more than 10 years. The interesting finding in this
study was all subjects who had developed CVD had duration
of diabetes less than 10 years at baseline. Such a link between
clustering of CVD risk factors and early onset of diabetes was
observed in a group of individuals with recently diagnosed
diabetes in a caseecontrol study conducted in South
Carolina.18
Baseline HbA1c values were not significantly associated
with CVD among the patients in contrast to the results re-
ported by Selvin et al19 In the present study, at baseline, most
of the study subjects, nearly 58%, had HbA1c 9% (75 mmol/
mol) and another 17.7% had their HbA1c between 7.5 and 9%
(58e75 mmol/mol), indicating poor glycemic control among
the study subjects, though they had not developed any com-
plications associated to diabetes. This observation may be
carefully interpreted since follow-up HbA1c values were notrecorded in this study, which would have an impact on the
development of CVD. Nevertheless, several pharmacological
interventional trials have also reported a non-significant
reduction in CVD-related events with a reduction in glycated
hemoglobin.20e22
Another important finding of this study was that patients
with type 2 diabetes andwith BMI25 kg/m2were twice at risk
of developing hypertension and dyslipidemia even after
adjusting for all confounding variables. This finding reiterates
that obesity plays a major role in the grouping of most of the
CVD risk factors among patientswith diabetes. In this context,
the positive effects of body weight reduction on CVD risk
factors such as systolic and diastolic blood pressure and other
lipid parameters and glycemic control have been reported in
the Look AHEAD trial conducted among 5145 patients with
diabetes.23
The association of modifiable risk factors such as smoking
habit, excessive alcohol consumption and increased BMI with
CVD and its risk factors and the effect of intensive lifestyle
intervention on reduction of CVD risk factors, as observed in
Look AHEAD trial, clearly state that a comprehensive treat-
ment comprising pharmacological management of diabetes
and intensive lifestyle modification for behavioral changes is
necessary to control the huge burden of CVD associated with
the exponential increase in the prevalence of diabetes in
India.
The most common complication developed among the
study subjects was neuropathy (14.4%), followed by retinop-
athy (7.6%) and CVD (6%). Similarly, Maji et al24 have reported
neuropathy to be an earlier and commonly occurring
complication among subjects with diabetes in India.
The study has few limitations. Only non-fatal CVD events
had been taken into account and there is a possibility of fatal
CVD during the 11 years period among the excluded subjects,
which could not be retrieved frommedical records. Moreover,
the other parameters such as increased waist circumference,
diet and physical activity adherence were not considered
because of non-availability of these data. Although this anal-
ysis is of retrospective type, it confirmed the strongassociation
of smokingandalcohol consumption andhigher BMIwithCVD
or its risk factors among subjects with diabetes. In addition, it
has tobenoted that there is a scarcity of studies lookingat such
an association in patients with diabetes. Hence, the present
findingsadd further knowledge to the existing literature on the
link between risk of developing non-fatal CVD events and
habitual risk factors such as smoking and heavy alcohol con-
sumption, especially in people with diabetes.5. Conclusions
In conclusion, the incident rate of non-fatal CVD events
among subjects with type 2 diabetes was 5.6 cases/1000
person-years. Smoking habit and alcohol consumption were
significantly associated with CVD events in Indian patients
with type 2 diabetes. In addition, obesity is strongly associated
with the development of clinical CVD risk factors such as
dyslipidemia and hypertension. Habitual risk factors and
obesity correction through lifestyle management should be
taken up with high priority and periodically reinforced among
i n d i a n h e a r t j o u rn a l 6 6 ( 2 0 1 4 ) 5e1 010these patients to delay or prevent the development of CVD
and its risk factors.Conflicts of interest
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